Unique ID issued by UMIN | UMIN000024771 |
---|---|
Receipt number | R000028418 |
Scientific Title | Effect of supplements containing fermented black garlic on hepatic function - a parallel randomized trial-. |
Date of disclosure of the study information | 2016/12/01 |
Last modified on | 2016/11/03 12:25:27 |
Effect of supplements containing fermented black garlic on hepatic function - a parallel randomized trial-.
Effect of fermented black garlic on hepatic function.
Effect of supplements containing fermented black garlic on hepatic function - a parallel randomized trial-.
Effect of fermented black garlic on hepatic function.
Japan |
Healthy adults
Adult |
Others
NO
To evaluate the efficacy of supplements containing fermented black garlic on hepatic functions of healthy Japanese
Efficacy
Confirmatory
Not applicable
Hepatic function (AST, ALT, LD, gamma-GTP, LAP)
Renal function (Urea nitrogen, Creatine, Uric acid)
Sugar metabolism (glucose, HbA1c)
Lipid metabolism (HDL-cholesterol, LDL-cholesterol, Triglycerides)
Physical measurements (Body weight, Body fat percentage, waist circumference, systolic blood pressure, diastolic blood pressure, heart beat)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
2
Prevention
Food |
Capsule containing fermented black garlic
334 mg of the garlic/day
Placebo capsule not containing fermented black garlic
30 | years-old | <= |
70 | years-old | > |
Male and Female
(1) persons who is generally judged as healthy
(2) persons who feel change in their body shapes and/or disturbance of the life
(1) persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficacy with the effect evaluated in this study
(2) persons who have changed their habitats to take supplements within past 4 weeks.
(3) Persons who work in night shift or in day and night shift
(4) persons who have been treated their illness or prevention in a clinic at their informed consent
(5) persons with their medical histories as follows: serious diseases of sugar metabolism,lipid metabolism, hepatic function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system
(6) persons with the medical histories of alcoholism or drug dependence
(7) persons who might be developed allergic reaction to foods.
(8) Persons who are pregnant, breast-feeding, or hope to be pregnant during the study period
(9) persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device)
(10) persons who will not be judged suitable to the participants by the investigator.
40
1st name | |
Middle name | |
Last name | Kuniyoshi Shimizu |
Faculty of Agriculture, Kyushu University
Laboratory of Systematic Forest and Forest Products Science
6-10-1 Hakozaki, Higashi-ku, Fukuoka, Fukuoka, JAPAN
092-642-3002
shimizu@agr.kyushu-u.ac.jp
1st name | |
Middle name | |
Last name | Kuniyoshi Shimizu |
Faculty of Agriculture, Kyushu University
Laboratory of Systematic Forest and Forest Products Science
6-10-1 Hakozaki, Higashi-ku, Fukuoka, Fukuoka, JAPAN
092-642-3002
shimizu@agr.kyushu-u.ac.jp
Faculty of Agriculture, Kyushu University
Miraikan Co. Ltd.,
Profit organization
Faculty of Humanity-Oriented Science and Engineering, Kindai University
NO
2016 | Year | 12 | Month | 01 | Day |
Unpublished
Completed
2016 | Year | 02 | Month | 13 | Day |
2016 | Year | 03 | Month | 10 | Day |
2016 | Year | 11 | Month | 08 | Day |
2016 | Year | 11 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028418